RxRevu, a provider of medication cost transparency solutions to identify cost-saving opportunities on prescription drugs, closed its Series B funding round of $7 million. JAZZ
RxRevu, a provider of medication cost transparency solutions to identify cost-saving opportunities on prescription drugs, closed its Series B funding round of $7 million. JAZZ